Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma

Pigment Cell and Melanoma Research

Volumn 21, Issue 3, 2008, Pages 358-367

  Hersey, Peter ^a   Zhang, Xu Dong ^a  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

Author keywords

ER stress; Hypoglycemia; Melanoma; New treatments; UPR

Indexed keywords

BORTEZOMIB; CELECOXIB; CISPLATIN; CURCUMIN; DIPYRIDAMOLE; EPIGALLOCATECHIN; GOSSYPOL; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; OMEPRAZOLE; PROTEIN INHIBITOR; PROTEIN MCL 1; PROTEIN P53; RAF PROTEIN; RAS PROTEIN; SORAFENIB; TW 37;

ADAPTATION; APOPTOSIS; AUTOPHAGY; CANCER GROWTH; CANCER RESISTANCE; CELL STRESS; DOWN REGULATION; ENDOPLASMIC RETICULUM; MELANOMA; REVIEW; SENESCENCE;

ADAPTATION, PHYSIOLOGICAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; HUMANS; MELANOMA; PROTEINS;

EID: 43549087613     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00467.x     Document Type: Review

References (94)

1. Armstrong, J.L., Veal, G.J., Redfern, C.P. Lovat, P.E. (2007). Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours. Apoptosis 12, 613 622.
2. Avery-Kiejda, K., Zhang, X.D., Adams, L.J., Scott, R.J., Vojtesek, B., Lane, D.P. Hersey, P. (2008). Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA damaging agent cisplatin. Clin. Cancer Res. 14, 1659 1668.
3. Baltzis, D., Pluquet, O., Papadakis, A.I., Kasemi, S., Qu, L.K. Koromilas, A.E. (2007). The EIF2alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of P53. J. Biol. Chem. 282, 31675 31687.
4. + homeostasis and apoptosis. EMBO J. 23, 1207 1216.
5. Baumann, O. Walz, B. (2001). Endoplasmic reticulum of animal cells and its organisation into structural and functional domains. Int Rev Cytol. 205, 149 214.
6. Bennett, D.C. (2008). How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res. 21, 27 38.
7. Bi, M., Naczki, C., Koritzinsky, M. et al. (2005). ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24, 3470 3481.
8. Bocharov, E.V., Pustovalova, Y.E., Pavlov, K.V. et al. (2007). Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 282, 16256 16266.
9. Brahimi-Horn, M.C. Pouyssegur, J. (2007). Harnessing the hypoxia-inducible factor in cancer and ischemic disease. Biochem. Pharmacol., 73, 450 457.
10. Chen, L.H., Jiang, C.C., Kiejda, K.A., Wang, Y.F., Mhaidat, N., Thorne, R., Zhang, X.D. Hersey, P. (2007a). Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein responses. Carcinogenesis 28, 2328 2336.
11. Chen, S., Dai, Y., Harada, H., Dent, P. Grant, S. (2007b). Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res. 67, 782 791.
12. D'Alessandro, G., Zardawi, I., Grace, J., McCarthy, W.H. Hersey, P. (1987). Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma. Pathology 19, 339 346.
13. De Milito, A., Iessi, E., Logozzi, M. et al. (2007). Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res. 67, 5408 5417.
14. van Delft, M.F., Wei, A.H., Mason, K.D. et al. (2006). The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10, 389 399.
15. Denoyelle, C., Abou-Rjaily, G., Bezrookove, V. et al. (2006). Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8, 1053 1063.
16. Dhawan, P., Singh, A.B., Ellis, D.L. Richmond, A. (2002). Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-κB and tumor progression. Cancer Res. 62, 7335 7342.
17. Ermakova, S.P., Kang, B.S., Choi, B.Y., Choi, H.S., Schuster, T.F., Ma, W.Y., Bode, A.M. Dong, Z. (2006). (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 66, 9260 9269.
18. Feldman, D. Koong, A.C. (2007). Irestatin, a potent inhibitor of IRE1α and the unfolded protein response, is a hypoxia-selective cytotoxin and impairs tumor growth. 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). J. Clin. Oncol. 25, 3514.
19. Fischer, K., Hoffmann, P., Voelki, S. et al. (2007). Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812 3819.
20. Fu, Y., Li, J. Lee, A.S. (2007). GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 67, 3734 3740.
21. Gillies, R.J. Gatenby, R.A. (2007). Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J. Bioenerg. Biomembr. 39, 251 257.
22. Goel, V.K., Lazar, A.J., Warneke, C.L., Redston, M.S. Haluska, F.G. (2006). Examination of mutations in BRAF, NRAS, and P TEN in primary cutaneous melanoma. J. Invest. Dermatol. 126, 154 160.
23. Graham, R.M., Thompson, J.W., Wei, J., Bishopric, N.H. Webster, K.A. (2007). Regulation of Bnip3 death pathways by calcium, phosphorylation, and hypoxia-reoxygenation. Antioxid. Redox Signal. 9, 1309 1315.
24. Haluska, F., Pemberton, T., Ibrahim, N. Kalinsky, K. (2007). The RTK/RAS/BRAF/P13K pathways in melanoma: biology, small molecule inhibitors, and potential applications. Semin. Oncol. 34, 546 554.
25. Hetz, C.A. 2007). ER stress signaling and the BCL-2 family of proteins: from adaptation to irreversible cellular damage. Antioxid. Redox Signal. 9, 2345 2355.
26. Hosoi, T., Hyoda, K., Okuma, Y., Nomura, Y. Ozawa, K. (2007). Akt up- and down-regulation in response to endoplasmic reticulum stress. Brain Res. 1152, 27 31.
27. Hu, P., Han, Z., Couvillon, A.D. Exton, J.H. (2004). Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279, 49420 49429.
28. Iwakoshi, N.N., Pypaert, M. Glimcher, L.H. (2007). The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J. Exp. Med. 204, 2267 2275.
29. Jiang, C.C., Chen, L.H., Gillespie, S., Kiejda, K.A., Mhaidat, N.M., Wang, Y.F., Thorne, R., Zhang, X.D. Hersey, P. (2007a). Tunicamycin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer Res. 67, 5880 5888.
30. Jiang, C.C., Chen, L.H., Gillespie, S., Wang, Y.F., Kiejda, K.A., Zhang, X.D. Hersey, P. (2007b). Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Cancer Res. 67, 9750 9761.
31. Jiang, C.C., Lucas, K., Avery-Kiejda, K.A., Wade, M., Thorne, R., Allen, J., Hersey, P. Zhang, X.D. (2008). Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon ER stress. Cancer Res. In press.
32. Kaneko, M., Yasui, S., Niinuma, Y., Arai, K., Omura, T., Okuma, Y. Nomura, Y. (2007). A different pathway in the endoplasmic reticulum stress-induced expression of human HRD1 and SEL1 genes. FEBS Lett. 581, 5355 5360.
33. Karst, A.M., Dai, D.L., Cheng, J.Q. Li, G. (2006). Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival. Cancer Res. 66, 9221 9226.
34. Kato, S. Du, K. (2007). TRB3 modulates C2C12 differentiation by interfering with Akt activation. Biochem. Biophys. Res. Commun. 353, 933 938.
35. Keilholz, U., Suciu, S., Bedikian, A.Y., Punt, C.J., Gore, M., Kruit, W., Pavlick, A.C., Spatz, A., Gilles, E. Eggermont, A.M. 2007). LDH is a prognostic factor in stage IV melanoma patients (pts) but is a predictive factor only for bcl2 antisense treatment efficacy: Re-analysis of GM301 and EORTC18951 randomized trials. American Society of Clinical Oncology Meeting, Abstract 8552, 485s.
36. Khayat, D., Meric, J.-B. Rixie, O. 2004). Systemic chemotherapy and biochemotherapy for non-resected and metastatic melanoma. In Textbook of Melanoma (ed. by J.F. Thompson, D.L. Morton B.B.R. Kroon London: Martin Dunitz pp. 586 601.
37. Kim, R., Emi, M., Tanabe, K. Murakami, S. (2006). Role of the unfolded protein response in cell death. Apoptosis 11, 5 13.
38. Kim, J.W., Gao, P., Liu, Y.C., Semenza, G.L. Dang, C.V. (2007). Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol., 27, 7381 7393.
39. Koong, A.C., Chauhan, V. Romero-Ramirez, L. (2006). Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biology & Therapy 5, 756 759.
40. Lai, E., Teodoro, T. Volchuk, A. (2007). Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 22, 193 201.
41. Lei, K. Davis, R.J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100, 2432 2437.
42. Li, J. Lee, A.S. (2006). Stress induction of GRP78/BiP and its role in cancer. Curr. Mol. Med. 6, 45 54.
43. Li, J., Lee, B. Lee, A.S. (2006). Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 281, 7260 7270.
44. Li, J., Tan, J., Zhuang, L., Banerjee, B., Yang, X., Chau, J.F., Lee, P.L., Hande, M.P., Li, B. Yu, Q. (2007). Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Cancer Res. 67, 11317 11326.
45. Lin, J.H., Li, H., Yasumura, D., Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M., LaVail, M.M. Walter, P. (2007). IRE1 signaling affects cell fate during the unfolded protein response. Science 318, 944 949.
46. Linder, S. Shoshan, M.C. (2005). Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist. Updat. 8, 199 204.
47. Luciani, F., Spada, M., De Milito, A. et al. (2004). Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J. Natl. Cancer Inst. 96, 1702 1713.
48. Luo, X., He, Q., Huang, Y. Sheikh, M.S. (2005). Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation. Cell Death Differ. 12, 1310 1318.
49. Mandic, A., Hansson, J., Linder, S. Shoshan, M.C. (2003). Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278, 9100 9106.
50. Manning, B.D. Cantley, L.C. (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261 1274.
51. Mathupala, S.P., Ko, Y.H. Pedersen, P.L. (2006). Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25, 4777 4786.
52. Maurer, U., Charvet, C., Wagman, A.S., Dejardin, E. Green, D.R. (2006). Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21, 749 760.
53. Mellor, H.R. Harris, A.L. (2007). The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev. 26, 553 566.
54. Mhaidat, N.M., Thorne, R.F., Zhang, X.D. Hersey, P. (2007a). Regulation of Docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. Mol. Cancer Res. 5, 1073 1081.
55. Mhaidat, N.M., Zhang, X.D., Jiang, C.C. Hersey, P. (2007b). Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin. Cancer Res. 13, 1308 1314.
56. Mohammad, R.M., Goustin, A.S., Aboukameel, A., Chen, B., Banerjee, S., Wang, G., Nikolovska-Coleska, Z., Wang, S. Al-Katib, A. (2007). Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. Clin. Cancer Res. 13, 2226 2235.
57. Nguyen, M., Marcellus, R.C., Roulston, A. et al. (2007). Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc. Natl Acad. Sci. U. S. A. 104, 19512 19517.
58. Nikiforov, M.A., Riblett, M., Tang, W.H. et al. (2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc. Natl Acad. Sci. U. S. A. 104, 19488 19493.
59. Pan, J.G. Mak, T.W. (2007). Metabolic targeting as an anticancer strategy: dawn of a new era? Sci. STKE Issue 381, pe14.
60. Park, H.R., Chijiwa, S., Furihata, K., Hayakawa, Y. Shin-Ya, K. (2007). Relative and absolute configuration of versipelostatin, a down-regulator of molecular chaperone GRP78 expression. Org Lett. 9, 1457 1460.
61. Parsons, D.W., Wang, T.-L., Samuels, Y. et al. (2005). Mutations in a signalling pathway. Nature 436, 792.
62. Pluquet, O., Qu, L.K., Baltzis, D. Koromilas, A.E. (2005). Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen syntase kinase 3beta. Mol. Cell. Biol. 25, 9392 9405.
63. Puthalakath, H., O'Reilly, L.A., Gunn, P. et al. (2007). ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129, 1337 1349.
64. Pyrko, P., Kardosh, A., Liu, Y.T. et al. (2007). Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induce by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. Mol. Cancer Ther. 6, 1262 1275.
65. Qin, J.Z., Xin, H., Sitailo, L.A., Denning, M.F. Nickoloff, B.J. (2006). Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. Cancer Res. 66, 9636 9645.
66. Qu, L., Huang, S., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A. Koromilas, A.E. (2004). Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β. Genes Dev. 18, 261 277.
67. Rahmani, M., Davis, E.M., Bauer, C., Dent, P. Grant, S. (2005). Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J. Biol. Chem 280, 35217 35227.
68. Rahmani, M., Davis, E.M., Crabtree, T.R., Habibi, J.R., Nguyen, T.K., Dent, P. Grant, S. (2007). The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Mol. Cell. Biol. 27, 5499 5513.
69. Rathmell, J.C., Fox, C.J., Plas, D.R., Hammerman, P.S., Cinalli, R.M. Thompson, C.B. (2003). Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23, 7315 7328.
70. Reddy, R.K., Mao, C., Baumeister, P., Austin, R.C., Kaufman, R.J. Lee, A.S. (2003). Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 278, 20915 20924.
71. Reimertz, C., Kogel, D., Rami, A., Chittenden, T. Prehn, J.H. (2003). Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J. Cell Biology 162, 587 597.
72. Robertson, G.P. (2005). Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev. 24, 273 285.
73. Rutkowski, D.T. Kaufman, R.J. (2007). That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem. Sci. 32, 469 476.
74. Scott, D.W. Loo, G. (2007). Curcumin-induced GADD153 upregulation: modulation by glutathione. J. Cell Biochem. 101, 307 320.
75. Shiraishi, T., Yoshida, T., Nakata, S., Horinaka, M., Wakada, M., Mizutani, Y., Miki, T. Sakai, T. (2005). Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res. 65, 6364 6370.
76. Smalley, K.S.M., Contractor, R., Haass, N.K. et al. (2007). An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res. 67, 209 217.
77. Szegezdi, E., Logue, S.E., Gorman, A.M. Samali, A. (2006). Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Reports 7, 880 885.
78. Thompson, K.L., Rosenzweig, B.A., Weaver, J.L., Zhang, J., Lin, K.K. Sistare, F.D. (2003). Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components. Toxicol. Sci. 74, 271 278.
79. Tovar, C., Rosinski, J., Filipovic, Z. et al. (2006). Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc. Natl. Acad. Sci. U. S. A. 103, 1888 1893.
80. Trudel, S., Li, Z.H., Rauw, J., Tiedemann, R.E., Wen, X.Y. Stewart, A.K. (2007). Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma. Blood 109, 5430 5438.
81. Tsao, H., Atkins, M.B. Sober, A.J. (2004). Management of cutaneous melanoma. N. Engl. J. Med. 351, 998 1012.
82. Vassilev, L.T. (2006). MDM2 inhibitors for cancer therapy. Trends Mol. Med. 13, 23 31.
83. Verhaegen, M., Bauer, J.A., Martin de la Vega, C. et al. (2006). A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res. 66, 11348 11359.
84. Vivanco, I. Sawyers, C.L. (2002). The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat. Rev. Cancer 2, 489 501.
85. Wang, W. el-Deiry, W.S. (2008). Restoration of p53 to limit tumor growth. Curr. Opin. Oncol. 200, 90 96.
86. Wang, Y.F., Jiang, C.C., Kiejda, K.A., Gillespie, S., Zhang, X.D. Hersey, P. (2007). Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin. Cancer Res. 13, 4934 4942.
87. Werno, C., Zhou, J. Brune, B 2008). A23187, ionomycin and thapsigargin upregulate mRNA of HIF-1alpha via endoplasmic reticulum stress rather than a rise in intracellular calcium. J. Cell. Physiol. 215, 708 714.
88. Wu, J. Kaufman, R.J. (2006). From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 13, 374 384.
89. Wu, J., Rutkowski, D.T., Dubois, M., Swathirajan, J., Saunders, T., Wang, J., Song, B., Yau, G.D.Y. Kaufman, R.J. (2007). ATF6α optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell 13, 351 364.
90. Yamamoto, K., Sato, T., Matsui, T., Sato, M., Okada, T., Yoshida, H., Harada, A. Mori, K. (2007). Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev. Cell 13, 365 376.
91. Yu, C., Bruzek, L.M., Meng, X.W., Gores, G.J., Carter, C.A., Kaufmann, S.H. Adjei, A.A. (2005). The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006. Oncogene 24, 6861 6869.
92. Zhang, F., Hamanaka, R.B., Bobrovnikova-Marjon, E., Gordan, J.D., Dai, M.S., Lu, H., Simon, M.C. Diehl, J.A. (2006). Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J. Biol. Chem. 281, 30036 30045.
93. Zhu, B., Wang, P., Zhang, X.D., Jiang, C.C., Chen, L.H., Avery-Kiejda, K.A., Watts, R. Hersey, P. (2008). Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells. Anticancer Drugs 19, 189 200.
94. Zhuang, L., Lee, C.S., Scolyer, R.A., McCarthy, S.W., Zhang, X.D., Thompson, J.F. Hersey, P. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Mod. Pathol. 20, 416 426.